International Stem Cell (ISCO) Assets Average (2011 - 2026)

International Stem Cell (ISCO) has reported Assets Average for 16 consecutive years, with $4.9 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Assets Average fell 11.6% year-over-year to $4.9 million in Q2 2026; TTM through Jun 2026 was $4.9 million, a 11.6% decrease from a year earlier, with the FY2025 full-year figure at $5.0 million, down 5.41% from the prior year.
• Assets Average was $4.9 million for Q2 2026 at International Stem Cell, down from $5.1 million in the prior quarter.
• Over five years, Assets Average peaked at $5.7 million in Q3 2023 and troughed at $4.9 million in Q2 2026.
• A 5-year average of $5.3 million and a median of $5.4 million in 2024 frame the typical range for Assets Average.
• Across the five-year window, Assets Average advanced 9.27% in 2023 and declined 11.6% in 2026, its largest moves.
• Over 5 years, Assets Average stood at $5.1 million in 2022, then advanced by 8.39% to $5.5 million in 2023, then declined by 6.15% to $5.2 million in 2024, then dropped by 2.43% to $5.1 million in 2025, then decreased by 2.24% to $4.9 million in 2026.
• The last three Assets Average figures came in at $4.9 million (Q2 2026), $5.1 million (Q4 2025), and $5.4 million (Q3 2025), per Business Quant data.